SEC Form 4 · accession 0001209191-19-008294
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
K Peony Yu
Officer — Chief Medical Officer
Period of report
Feb 5, 2019
Accepted (ET)
Feb 7, 2019 · 7:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 5, 2019 | A | 33,100 | $0.00 | A | 177,223 | D | |
| Common StockF2 | Feb 5, 2019 | A | 20,000 | $0.00 | A | 197,223 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $57.33 | Feb 5, 2019 | A | 55,200 | A | — | Feb 5, 2029 | Common Stock | 55,200 | 55,200 | D |
Explanation of responses
- F1Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2020, and the remainder vests in equal amounts quarterly thereafter for the following three years.
- F2Represents the grant of restricted stock units. Fifty percent of the restricted stock units vest on each of September 6, 2019 and March 6, 2020.
- F3Twenty-five percent of the shares subject to the option vests on March 1, 2020, and the remainder vests in equal amounts quarterly thereafter for the following three years.